Skip to main content

Medications for Multiple Sclerosis - Page 3

The medications listed below are related to or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
dexamethasone 10 1 review for dexamethasone to treat Multiple Sclerosis Rx C N
Generic name:
dexamethasone systemic
Brand names:
Dexamethasone Intensol, De-Sone LA, Dxevo, HiDex
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Dexamethasone Intensol Rate Add review Rx C N
Generic name:
dexamethasone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
De-Sone LA Rate Add review Rx C N
Generic name:
dexamethasone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
dalfampridine 7.8 83 reviews for dalfampridine to treat Multiple Sclerosis Rx C N
Generic name:
dalfampridine systemic
Brand name:
Ampyra
Drug class:
miscellaneous central nervous system agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
cyclophosphamide Off-label 6.0 3 reviews for cyclophosphamide to treat Multiple Sclerosis Rx D N
Generic name:
cyclophosphamide systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
corticotropin 5.0 10 reviews for corticotropin to treat Multiple Sclerosis Rx C N
Generic name:
corticotropin systemic
Brand names:
Acthar, H.P. Acthar Gel
Drug class:
corticotropin
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Copaxone 7.6 133 reviews for Copaxone to treat Multiple Sclerosis Rx B N
Generic name:
glatiramer systemic
Drug class:
other immunostimulants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
cladribine 8.2 6 reviews for cladribine to treat Multiple Sclerosis Rx D N
Generic name:
cladribine systemic
Brand name:
Mavenclad
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Briumvi 8.3 11 reviews for Briumvi to treat Multiple Sclerosis Rx N
Generic name:
ublituximab systemic
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Betaseron 6.9 8 reviews for Betaseron to treat Multiple Sclerosis Rx C N X
Generic name:
interferon beta-1b systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Bafiertam Rate Add review Rx N
Generic name:
monomethyl fumarate systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
azathioprine 4.5 2 reviews for azathioprine to treat Multiple Sclerosis Rx D N
Generic name:
azathioprine systemic
Brand names:
Imuran, Azasan
Drug class:
antirheumatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Azasan Rate Add review Rx D N
Generic name:
azathioprine systemic
Drug class:
antirheumatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Avonex Prefilled Syringe 9.0 5 reviews for Avonex Prefilled Syringe to treat Multiple Sclerosis Rx C N X
Generic name:
interferon beta-1a systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
Avonex Pen 8.8 13 reviews for Avonex Pen to treat Multiple Sclerosis Rx C N X
Generic name:
interferon beta-1a systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
Avonex 7.2 45 reviews for Avonex to treat Multiple Sclerosis Rx C N X
Generic name:
interferon beta-1a systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Aubagio 5.4 86 reviews for Aubagio to treat Multiple Sclerosis Rx X N X
Generic name:
teriflunomide systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Ampyra 8.0 77 reviews for Ampyra to treat Multiple Sclerosis Rx C N
Generic name:
dalfampridine systemic
Drug class:
miscellaneous central nervous system agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
alemtuzumab 6.5 21 reviews for alemtuzumab to treat Multiple Sclerosis Rx C N
Generic name:
alemtuzumab systemic
Brand name:
Lemtrada
Drug class:
CD52 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Acthar 3.8 5 reviews for Acthar to treat Multiple Sclerosis Rx C N
Generic name:
corticotropin systemic
Drug class:
corticotropin
For consumers:
dosage, interactions, side effects

Frequently asked questions

View more FAQ

Topics under Multiple Sclerosis

Learn more about Multiple Sclerosis

Care guides

Symptoms and treatments

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.